electroCore Expands Manufacturing Capabilities for gammaCore™
“We are pleased to announce expansion into this new design, development and manufacturing facility which will ensure we can meet growing patient demand for gammaCore,” said
The 13,640-square-foot office and manufacturing facility is located at
electroCore, Inc. was founded in 2005 with the mission to help patients worldwide who suffer from pain and chronic conditions. The company’s first product, gammaCore, was cleared by the
About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology and rheumatology. The Company’s initial targets are the acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
Greg Chodaczek or Lynn Lewis